Nandita Shangari
Angel · Massachusetts
Board director at 3 startups that filed Form D raises since late 2024, mostly in Massachusetts.
- Stages
- Series B, Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- May 2024
Focus
Biotech & PharmaHealthcareRecent portfolio activity
Sources
- SEC Form D: Superluminal MedicinesAug 28, 2023
- SEC Form D: Capstan TherapeuticsMar 20, 2024
- SEC Form D: Halda TherapeuticsMay 24, 2024
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.